Hepatitis B virus infection in children

Area of Science:

• Pediatric Infectious Diseases
• Hepatology
• Vaccinology

Background:

• Hepatitis B vaccination is standard in childhood programs, decreasing HBsAg prevalence.
• Gaps in vaccine access persist in certain regions, leaving some children susceptible.
• Chronic hepatitis B infection in children can lead to severe outcomes like cirrhosis and liver cancer.

Purpose of the Study:

• To review the clinical outcomes of chronic hepatitis B virus infection in children.
• To discuss the controversies surrounding treatment initiation and drug selection for pediatric hepatitis B.
• To highlight the need for more research on hepatitis B pathogenesis and antiviral efficacy in children.

Main Methods:

• Review of long-term follow-up studies on childhood hepatitis B infection.
• Analysis of current data on antiviral drug approvals and usage in pediatric populations.
• Examination of strategies for preventing mother-to-child transmission of hepatitis B virus.

Main Results:

• While vaccination has decreased HBsAg prevalence, chronic infection still occurs in some children.
• A subset of chronically infected children face risks of liver cirrhosis and hepatocellular carcinoma.
• Data on the efficacy and optimal treatment protocols for pediatric hepatitis B are limited compared to adults.

Conclusions:

• Despite widespread vaccination, challenges remain in preventing and treating hepatitis B in children.
• Further research is crucial to establish evidence-based guidelines for antiviral therapy in pediatric hepatitis B.
• Antiviral interventions, including in pregnant women, are vital for reducing transmission and managing infection.